Educational Session 8: The Illusion of Precision: Therapies without Molecular Selection for Hormone Receptor Positive Metastatic Breast Cancer 

Moderator

Komal L Jhaveri

Presentation numberED8-01

Current Landscape with Endocrine-Based Treatment in HR+/HER2- MBC

Kevin Kalinsky, Emory Winship Cancer Institute, Atlanta, GA

Presentation numberED8-02

Novel CDK Inhibitors

Timothy Yap, University of Texas MD Anderson Cancer Center, Houston, TX

Presentation numberED8-03

Emerging Targeted Approaches in the Treatment of HR Positive MBC

Ezra Rosen

TBD

Kimberly Parekh